DK0541729T3 - Stabiliseret anoxisk diagnostisk reagensopløsning - Google Patents

Stabiliseret anoxisk diagnostisk reagensopløsning

Info

Publication number
DK0541729T3
DK0541729T3 DK91919544.6T DK91919544T DK0541729T3 DK 0541729 T3 DK0541729 T3 DK 0541729T3 DK 91919544 T DK91919544 T DK 91919544T DK 0541729 T3 DK0541729 T3 DK 0541729T3
Authority
DK
Denmark
Prior art keywords
stabilized
anoxic
reagent
reagent solution
diagnostic reagent
Prior art date
Application number
DK91919544.6T
Other languages
Danish (da)
English (en)
Inventor
Louis Saldivar Jr
Barbara J England
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK0541729T3 publication Critical patent/DK0541729T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/665—Assays involving proteins derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • G01N2333/675—Assays involving proteins derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin beta-Endorphins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/80—Multi-analyte reference solutions containing cholesterol, glucose and the like
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/801—Anerobic cultivation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y10T436/146666—Bile pigment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK91919544.6T 1990-10-22 1991-10-18 Stabiliseret anoxisk diagnostisk reagensopløsning DK0541729T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60079790A 1990-10-22 1990-10-22

Publications (1)

Publication Number Publication Date
DK0541729T3 true DK0541729T3 (da) 1997-06-02

Family

ID=24405090

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91919544.6T DK0541729T3 (da) 1990-10-22 1991-10-18 Stabiliseret anoxisk diagnostisk reagensopløsning

Country Status (9)

Country Link
US (1) US5401639A (de)
EP (1) EP0541729B1 (de)
AT (1) ATE146821T1 (de)
AU (1) AU8874591A (de)
DE (1) DE69123848T2 (de)
DK (1) DK0541729T3 (de)
ES (1) ES2098377T3 (de)
GR (1) GR3022831T3 (de)
WO (1) WO1992007088A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296377A (en) * 1992-12-15 1994-03-22 Boehringer Mannheim Corporation Control reagent containing a hydroxylamine or an antioxidant
KR970022316A (ko) * 1995-10-27 1997-05-28 후루야 아끼라 빌리루빈의 정량 방법
ES2183999T3 (es) * 1996-03-22 2003-04-01 Roche Diagnostics Gmbh Estabilizacion de bilirrubina en sueros de control y en calibradores.
US7374905B2 (en) * 2000-11-08 2008-05-20 Oxyrase, Inc. Medium composition, method and device for selectively enhancing the isolation of anaerobic microorganisms contained in a mixed sample with facultative microorganisms
GB0207533D0 (en) 2002-04-02 2002-05-08 Oxford Glycosciences Uk Ltd Protein
CA2579001C (en) * 2004-09-01 2014-07-08 Maine Standards Company, Llc Novel stable lipid standards
KR100579467B1 (ko) 2005-04-18 2006-05-15 (주)메드멕스 세포학적 진단을 위한 보조용액
WO2008104803A2 (en) 2007-02-26 2008-09-04 Oxford Genome Sciences (Uk) Limited Proteins
EP2447719B1 (de) 2007-02-26 2016-08-24 Oxford BioTherapeutics Ltd Proteine
CA2750581A1 (en) 2009-01-21 2010-07-29 Oxford Biotherapeutics Ltd. Pta089 protein
US20120282177A1 (en) 2009-11-02 2012-11-08 Christian Rohlff ROR1 as Therapeutic and Diagnostic Target
RS55716B1 (sr) 2011-06-28 2017-07-31 Oxford Biotherapeutics Ltd Terapeutski i dijagnostički cilj
GB201213652D0 (en) 2012-08-01 2012-09-12 Oxford Biotherapeutics Ltd Therapeutic and diagnostic target
GB201302447D0 (en) 2013-02-12 2013-03-27 Oxford Biotherapeutics Ltd Therapeutic and diagnostic target
WO2022127933A1 (zh) * 2020-12-18 2022-06-23 深圳市绘云生物科技有限公司 新生儿胆道闭锁生物标志物的应用及检测方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1095819A (en) * 1977-01-14 1981-02-17 Eastman Kodak Company Element for analysis of liquids
US4414334A (en) * 1981-08-07 1983-11-08 Phillips Petroleum Company Oxygen scavenging with enzymes
US4476224A (en) * 1982-05-10 1984-10-09 Adler Howard I Material and method for promoting the growth of anaerobic bacteria
JPS6040957A (ja) * 1983-08-15 1985-03-04 Toyobo Co Ltd 抱合型ビリルビンの安定化法
US4775626A (en) * 1986-05-23 1988-10-04 Syntex (U.S.A.) Inc. Method and compositions for protecting anerobic microorganisms
US5047395A (en) * 1990-07-17 1991-09-10 Nagase Co., Ltd. Reduction of oxyradical damage in biomedical applications

Also Published As

Publication number Publication date
GR3022831T3 (en) 1997-06-30
DE69123848D1 (de) 1997-02-06
EP0541729A4 (en) 1994-09-28
EP0541729B1 (de) 1996-12-27
WO1992007088A1 (en) 1992-04-30
EP0541729A1 (de) 1993-05-19
AU8874591A (en) 1992-05-20
ATE146821T1 (de) 1997-01-15
ES2098377T3 (es) 1997-05-01
DE69123848T2 (de) 1997-07-10
US5401639A (en) 1995-03-28

Similar Documents

Publication Publication Date Title
DK0541729T3 (da) Stabiliseret anoxisk diagnostisk reagensopløsning
GB8425872D0 (en) Chemical compounds
AU578947B2 (en) Pyridazinones,preparation process thereof and utilization thereof, drugs containing pyridazinones
DE68915715D1 (de) Membran-Blutoxygenator.
DK0845970T3 (da) Pose til at indeholde en steril medicinsk opløsning og fremgangsmåde til opblanding af en steril medicinsk opløsning
ATE368385T1 (de) Molkereistarterkultur-abgabesystem und dessen verwendung
DE69811709D1 (de) Bekämpfungsmittel gegen pflanzenpathogene mikro-organismen
Dubos The relation of the bacteriostatic action of certain dyes to oxidation-reduction processes
BR0111095A (pt) Recipiente de múltiplos compartimentos para soluções médicas estéreis, solução médica estéril, e, método de estabilização e uso de uma solução médica estéril contendo carboidrato
GR3003870T3 (de)
ATE57917T1 (de) Hydroxipyrazol-derivate- verfahren zu ihrer herstellung und ihre verwendung gegen mikroorganismen.
CA2080820A1 (fr) Derives azoiques, compositions pharmaceutiques et desinfectantes les contenant et leurs utilisations
DK0904234T3 (da) Medicinsk beholder
ATE90354T1 (de) Polydeoxyribonukleotide, pharmazeutische zusammensetzungen, verwendung und herstellung von polydeoxyribonukleotiden.
DE68921418D1 (de) Imidazochinoxaline und ihre Herstellung.
Neill STUDIES ON THE OXIDATION-REDUCTION OF HEMOGLOBIN AND METHEMOGLOBIN: I. THE CHANGES INDUCED BY PNEUMOCOCCI AND BY STERILE ANIMAL TISSUE
AU6578086A (en) An agent for the determination of peroxidase activity, a process for its preparation and its use
US4886779A (en) Inactivation of human immunodeficiency virus (HIV) in protein-containing solutions by phenols
DE69116803D1 (de) Peroxidase-Gen von mikrobischem Ursprung
SE8500093L (sv) Urokinasderivat
ATE16102T1 (de) Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung.
Saldivar et al. Stabilized bilirubin calibrator solution and method therefor
Brasseur et al. Conformational analysis of the calcium-antagonist gallopamil
ATE4637T1 (de) Pentadecapeptid, verfahren zu seiner herstellung und immunisierendes mittel.
KR880001825A (ko) 발효에 의한 5'-구아닐산의 제조방법